Publication | Open Access

A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis

Tlpldc VaccineSurgical OncologyOncologyMelanomaImmunologyVaccine TrialTherapeutic VaccineStage Iii/iv MelanomaAdjuvant TherapyMedicine